Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study.
<h4>Background</h4>Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often delayed, increasing the risk of spread to the community and health care workers. Treatment is prolonged, and the total cost of treating a single case is high. Diagnosis...
Guardado en:
Autores principales: | Philly O'Riordan, Uli Schwab, Sarah Logan, Graham Cooke, Robert J Wilkinson, Robert N Davidson, Paul Bassett, Robert Wall, Geoffrey Pasvol, Katie L Flanagan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc253087c17a40e1ae2f760eac475ef4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IDENTIFICATION OF MUTATIONS OF RESISTANCE TO FLUOROQUINOLONES, AMINOGLYCOSIDES AND ETHAMBUTOL IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS
por: I. V. Bakshtanovskaya, et al.
Publicado: (2018) -
Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021) -
Rifampicin-Resistant Serotype B Neisseria meningitidis: First Case in Portugal
por: Cláudia Silva, et al.
Publicado: (2021) -
Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Anwar Sheed Khan, et al.
Publicado: (2021) -
Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
por: Lisa Nkatha Micheni, et al.
Publicado: (2021)